Gm71 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Gm71 gene, a relatively uncharacterized gene thought to play a role in cellular processes such as gene expression regulation, intracellular signaling, and protein interactions. Although little is known about the precise functions of Gm71, genes like Gm71 are often involved in key biological pathways that influence cellular development, differentiation, and maintenance of cellular homeostasis. Gm71 may contribute to regulatory networks that control transcription or modulate the response of cells to external stimuli. By inhibiting Gm71, researchers can explore its specific function within these processes, allowing for a better understanding of its role in maintaining cellular stability and modulating gene expression.
In research, Gm71 inhibitors provide a valuable tool for investigating the molecular mechanisms regulated by Gm71. By blocking the activity of Gm71, scientists can observe changes in cellular function, such as disruptions in gene expression profiles, alterations in protein-protein interactions, or shifts in intracellular signaling pathways. These inhibitors allow researchers to explore how Gm71 contributes to critical cellular processes, including cell growth, differentiation, and the cellular response to environmental stressors. Additionally, Gm71 inhibitors help uncover potential interactions between Gm71 and other regulatory molecules, providing insight into the complex networks that control cellular behavior. By using Gm71 inhibitors, researchers can enhance their understanding of the role of lesser-known genes in gene regulation and intracellular communication, shedding light on the broader systems that maintain cellular function and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
Interferes with the endoplasmic reticulum-associated degradation (ERAD) pathway, where VCP is involved, possibly affecting VCPKMT's substrate availability. | ||||||
NMS-873 | 1418013-75-8 | sc-478803 | 5 mg | $300.00 | ||
An allosteric VCP inhibitor that can disrupt VCP function, which may affect VCPKMT by altering its substrate's conformation or availability. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
A selective VCP ATPase inhibitor that may indirectly affect VCPKMT by hindering VCP's cellular functions. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
Known to interfere with DNA damage response, where VCP plays a role, possibly affecting VCPKMT by altering VCP's interaction with damaged DNA. | ||||||
ONX 0914 | 960374-59-8 | sc-477437 | 5 mg | $245.00 | ||
An inhibitor of the immunoproteasome, where VCP is involved, potentially affecting VCPKMT's regulation of VCP. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
Targets the ubiquitin-proteasome system, wherein VCP is a key component, possibly affecting VCPKMT's activity due to altered VCP function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can indirectly affect VCP function and thereby potentially influence VCPKMT activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can disrupt the degradation pathway involving VCP, potentially impacting VCPKMT activity. | ||||||